Repeat Prescriptions

Bod Australia achieves quarter-on-quarter sales growth of 61%

Finfeed Archived Apr 01, 2021

Bod Australia (ASX: BDA) achieved record medicinal cannabis sales growth in the March quarter, filling 3789 MediCabilis™ prescriptions.